Multimodal Evaluation of the Anxiolytic Activity of Phyllanthus niruri Extract in Mice: A Comparative Behavioral and Neuropharmacological Approach
Abstract
Anxiety is a widespread mental health issue that impacts millions of individuals globally, often interfering with daily functioning and overall well-being. While conventional anti-anxiety medications like benzodiazepines are widely used, their prolonged use is often limited due to side effects such as sedation, dependence, and drug tolerance. As a result, there is increasing interest in exploring herbal remedies with better safety profiles. Phyllanthus niruri Linn., a medicinal herb widely recognized in Ayurvedic medicine for treating liver and urinary problems, is known to contain neuroactive constituents such as flavonoids, tannins, phenolics, and alkaloids. This study aimed to assess the anti-anxiety potential of the hydroalcoholic extract of Phyllanthus niruri in Swiss albino mice using multiple validated behavioral models. The plant was collected and authenticated, then extracted using a 70:30 ethanol-water mixture and screened for key phytochemical constituents. Mice were randomly assigned into four groups: a control group, a standard group receiving diazepam (2 mg/kg), and two test groups treated orally with the extract at 100 mg/kg and 200 mg/kg. Behavioral tests including the Elevated Plus Maze (EPM), Open Field Test (OFT), Actophotometer, and Rotarod were conducted to evaluate anxiety levels, movement activity, and motor coordination. The extract demonstrated a dose-related reduction in anxiety-like behaviors, with effects comparable to the standard drug, and did not cause significant motor impairment. Phytochemical screening confirmed the presence of active compounds likely responsible for the observed anxiolytic action. These findings support the traditional claims of Phyllanthus niruri in stress relief and highlight its potential as a safe, natural alternative for managing anxiety disorders.
Keywords: Phyllanthus niruri, anxiolytic activity, hydroalcoholic extract, behavioral models
Keywords:
phyllanthus niruri, anxiety, stress, open field test, actophotometer, rotarod, corticosteroneDOI
https://doi.org/10.22270/jddt.v15i9.7333References
1. Craske MG, Rauch SL, Ursano R, Prenoveau J, Pine DS, Zinbarg RE. What Is an Anxiety Disorder?
2. Julian LJ. Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A). Arthritis Care Res (Hoboken). 2011 Nov;63(SUPPL. 11). https://doi.org/10.1002/acr.20561 PMid:22588767 PMCid:PMC3879951
3. Anxiety Disorders: Causes, Types, Symptoms, & Treatments [Internet]. healthline . [cited 2025 Jun 20]. Available from: https://www.healthline.com/health/anxiety
4. LeDoux JE, Pine DS. Using neuroscience to help understand fear and anxiety: A two-system framework. Vol. 173, American Journal of Psychiatry. American Psychiatric Association; 2016. p. 1083-93. https://doi.org/10.1176/appi.ajp.2016.16030353 PMid:27609244
5. Understanding Anxiety: The Complete Beginner's Guide [Internet]. nickwignall. [cited 2025 Jun 20]. Available from: https://nickwignall.com/understanding-anxiety/
6. Martin P. The epidemiology of anxiety disorders: A review. Vol. 5, Dialogues in Clinical Neuroscience. 2003. p. 281-98. https://doi.org/10.31887/DCNS.2003.5.3/pmartin PMid:22034470 PMCid:PMC3181629
7. Ströhle A, Gensichen J, Domschke K. Diagnostik und Therapie von Angsterkrankungen. Dtsch Arztebl Int. 2018 Sep 14;115(37):611-20.
8. Craske MG, Waters AM. Panic disorder, phobias, and generalized anxiety disorder. Vol. 1, Annual Review of Clinical Psychology. 2005. p. 197-225. https://doi.org/10.1146/annurev.clinpsy.1.102803.143857 PMid:17716087
9. Morrison AS, Heimberg RG. Social anxiety and social anxiety disorder. Vol. 9, Annual Review of Clinical Psychology. 2013. p. 249-74. https://doi.org/10.1146/annurev-clinpsy-050212-185631 PMid:23537485
10. LeBeau RT, Glenn D, Liao B, Wittchen HU, Beesdo-Baum K, Ollendick T, et al. Specific phobia: A review of DSM-IV specific phobia and preliminary recommendations for DSM-V. Vol. 27, Depression and Anxiety. 2010. p. 148-67. https://doi.org/10.1002/da.20655 PMid:20099272
11. Bögels SM, Knappe S, Clark LA. Adult separation anxiety disorder in DSM-5. Vol. 33, Clinical Psychology Review. 2013. p. 663-74. https://doi.org/10.1016/j.cpr.2013.03.006 PMid:23673209
12. Lewinsohn PM, Holm-Denoma JM, Small JW, Seeley JR, Joiner TE. Separation anxiety disorder in childhood as a risk factor for future mental illness. J Am Acad Child Adolesc Psychiatry. 2008;47(5):548-55. https://doi.org/10.1097/CHI.0b013e31816765e7 PMid:18356763 PMCid:PMC2732357
13. Veale D, Roberts A. Obsessive-compulsive disorder. Vol. 348, BMJ (Online). BMJ Publishing Group; 2014. https://doi.org/10.1136/bmj.g2183 PMid:24709802
14. Litz B 1, Keane TM. INFORMATION PROCESSING IN ANXIETY DISORDERS: APPLICATION TO THE UNDERSTANDING OF POST-TRAUMATIC STRESS DISORDER. Vol. 9, Climim Psychology R&w. 1989. https://doi.org/10.1016/0272-7358(89)90030-5
15. Gordon RP, Brandish EK, Baldwin DS. Anxiety disorders, post-traumatic stress disorder, and obsessive-compulsive disorder. Vol. 44, Medicine (United Kingdom). Elsevier Ltd; 2016. p. 664-71. https://doi.org/10.1016/j.mpmed.2016.08.010
16. Marcus DK, Gurley JR, Marchi MM, Bauer C. Cognitive and perceptual variables in hypochondriasis and health anxiety: A systematic review. Clin Psychol Rev. 2007 Mar;27(2):127-39. https://doi.org/10.1016/j.cpr.2006.09.003 PMid:17084495
17. Weck F, Richtberg S, Neng JMB. Send Orders for Reprints to reprints@benthamscience.net Epidemiology of Hypochondriasis and Health Anxiety: Comparison of Different Diagnostic Criteria. Vol. 10, Current Psychiatry Reviews. 2014. https://doi.org/10.2174/1573400509666131119004444
18. Current Diagnosis and Treatment of Anxiety Disorders.
19. Lee NYS, Khoo WKS, Adnan MA, Mahalingam TP, Fernandez AR, Jeevaratnam K. The pharmacological potential of Phyllanthus niruri. Journal of Pharmacy and Pharmacology. Blackwell Publishing Ltd; 2016. p. 953-69. https://doi.org/10.1111/jphp.12565 PMid:27283048
20. Kp V. Various health benefits and phyto chemical constituents of Phyllantus niruri. ~ 1886 ~ The Pharma Innovation Journal [Internet]. 2022;11(6):1886-95. Available from: www.thepharmajournal.com
21. Markom M, Hasan M, Daud WRW, Singh H, Jahim JM. Extraction of hydrolysable tannins from Phyllanthus niruri Linn.: Effects of solvents and extraction methods. Sep Purif Technol. 2007 Jan;52(3):487-96. https://doi.org/10.1016/j.seppur.2006.06.003
22. Bagalkotkar G, Sagineedu SR, Saad MS, Stanslas J. Phytochemicals from Phyllanthus niruri Linn. and their pharmacological properties: a review . Journal of Pharmacy and Pharmacology. 2006 Dec 1;58(12):1559-70. https://doi.org/10.1211/jpp.58.12.0001 PMid:17331318
23. Singh T, Ruchi, Singh A, Kumar R, Singh JK. Acute toxicity study of Phyllanthus niruri and its effect on the cyto-architectural structure of nephrocytes in Swiss albino mice Mus-musculus. Pharmacognosy Journal. 2016;8(1):77-80. https://doi.org/10.5530/pj.2016.1.17
24. Asare GA, Addo P, Bugyei K, Gyan B, Adjei S, Otu-Nyarko LS, et al. Acute toxicity studies of aqueous leaf extract of Phyllanthus niruri. Interdiscip Toxicol. 2011 Dec 1;4(4):206-10. https://doi.org/10.2478/v10102-011-0031-9 PMid:22319255 PMCid:PMC3274729
25. NEUROPHARMACOLOGICAL STUDY OF PHYLLANTHUS NIRURI IN SWISS ALBINO MICE. 2021; Available from: http://dx.doi.org/10.22159/ajpcr.2021v14i4.40343 .
26. Schwarz A, Márlisson de Queiroz F, Wanderson de Oliveira Matias K, Mylana Freire da Cunha M, Schwarz A, Queiroz FM, et al. Evaluation of (anti)genotoxic activities of Phyllanthus niruri L. in rat bone marrow using the micronucleus test. Vol. 49, Article Brazilian Journal of Pharmaceutical Sciences. 2013. https://doi.org/10.1590/S1984-82502013000100015
27. Chopade AR, Somade PM, Somade PP, Mali SN. Identification of Anxiolytic Potential of Niranthin: In-vivo and Computational Investigations. Nat Prod Bioprospect. 2021 Apr 1;11(2):223-33. https://doi.org/10.1007/s13659-020-00284-8 PMid:33175328 PMCid:PMC7981351
28. Bourin M. Animal models for screening anxiolytic-like drugs: a perspective [Internet]. Vol. 17, Dialogues Clin Neurosci. 2015. Available from: www.dialogues-cns.org https://doi.org/10.31887/DCNS.2015.17.3/mbourin PMid:26487810 PMCid:PMC4610614
29. Cryan JF, Sweeney FF. Themed Issue: Translational Neuropharmacology-Using Appropriate Animal Models to Guide Clinical Drug Development The age of anxiety: role of animal models of anxiolytic action in drug discovery. 2011; https://doi.org/10.1111/j.1476-5381.2011.01362.x PMid:21545412 PMCid:PMC3229755
30. Walf AA, Frye CA. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc. 2007 Mar;2(2):322-8. https://doi.org/10.1038/nprot.2007.44 PMid:17406592 PMCid:PMC3623971
31. Anti-Anxiety Effects of Mercurialis Annua Aqueous Extract in the Elevated Plus Maze Test.
32. Mahendra P, Bisht S. Anti-anxiety activity of Coriandrum sativum assessed using different experimental anxiety models. Indian J Pharmacol. 2011 Oct;43(5):574-7. https://doi.org/10.4103/0253-7613.84975 PMid:22022003 PMCid:PMC3195130
33. Gupta G, Jia Jia T, Yee Woon L, Kumar Chellappan D, Candasamy M, Dua K. Pharmacological Evaluation of Antidepressant-Like Effect of Genistein and Its Combination with Amitriptyline: An Acute and Chronic Study. Adv Pharmacol Sci. 2015;2015. https://doi.org/10.1155/2015/164943 PMid:26681936 PMCid:PMC4670631
34. Bhosale U, Yegnanarayan R, Prachi P, Zambare M, Somani RS. Study of cns depressant and behavioral activity of an ethanol extract of achyranthes aspera (chirchita) in mouse model. Ann Neurosci. 2011 Apr;18(2):44-7. https://doi.org/10.5214/ans.0972.7531.1118204 PMid:25205920 PMCid:PMC4117029
35. Thippeswamy BS, Mishra B, Veerapur VP, Gupta G. Anxiolytic activity of Nymphaea alba Linn. in mice as experimental models of anxiety. Indian J Pharmacol. 2011 Feb;43(1):50-5. https://doi.org/10.4103/0253-7613.75670 PMid:21455422 PMCid:PMC3062121
36. Kudagi BL. Evaluation of Anti - Anxiety, Sedative and Motor Co-Ordination Properties of Ganaxolone in Comparison with Diazepam in Rodent Models. IOSR Journal of Dental and Medical Sciences. 2012;1(4):42-7. https://doi.org/10.9790/0853-0144247
37. Huang L, Xiao D, Sun H, Qu Y, Su X. Behavioral tests for evaluating the characteristics of brain diseases in rodent models: Optimal choices for improved outcomes (Review). Mol Med Rep. 2022 May 1;25(5). https://doi.org/10.3892/mmr.2022.12699 PMid:35348193
38. Gong S, Miao YL, Jiao GZ, Sun MJ, Li H, Lin J, et al. Dynamics and correlation of serum cortisol and corticosterone under different physiological or stressful conditions in mice. PLoS One. 2015 Feb 20;10(2). https://doi.org/10.1371/journal.pone.0117503 PMid:25699675 PMCid:PMC4336318
39. Dubey VK, Ansari F, Vohora D, Khanam R. Possible involvement of corticosterone and serotonin in antidepressant and antianxiety effects of chromium picolinate in chronic unpredictable mild stress induced depression and anxiety in rats. Journal of Trace Elements in Medicine and Biology. 2015 Jan 1;29:222-6. https://doi.org/10.1016/j.jtemb.2014.06.014 PMid:25037773
40. Kim S, Foong D, Cooper MS, Seibel MJ, Zhou H. Comparison of blood sampling methods for plasma corticosterone measurements in mice associated with minimal stress-related artefacts. Steroids. 2018 Jul 1;135:69-72. https://doi.org/10.1016/j.steroids.2018.03.004 PMid:29548771
Published
Abstract Display: 519 
PDF Downloads: 421 PDF Downloads: 22 How to Cite
Issue
Section
Copyright (c) 2025 Kuldeep Prajapati , Mangesh Tote , Subhendu Mathur , Juverya Kazi , Abhishek Prajapati , Sahil Patil
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.